A groundbreaking artificial intelligence tool, known as DT-GPT, has been developed to create virtual representations of patients, enabling precise predictions of individual health trajectories. Researchers at...
The European Commission (EC) has granted approval for tislelizumab (Tevimbra) as a combination treatment for adults with resectable non-small cell lung cancer (NSCLC) at high risk...
